Plain-English translation of NCT07385131 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying whether you need preventive steroids (a medication called dexamethasone) before each infliximab infusion, or whether you can skip this extra medication if you had no allergic reaction during your previous treatment. The study wants to figure out the safest and most practical way to prevent allergic reactions during this treatment, without giving unnecessary medications.
Many patients receive preventive steroids before every infusion as routine practice, but doctors are unsure whether this is always necessary. This study aims to reduce unnecessary medication use, shorten treatment sessions, and ease the burden on patients while keeping them safe—potentially saving time, money, and avoiding unwanted side effects from extra steroids.
You likely qualify if…
You likely don't qualify if…
You will receive infliximab infusions as part of your regular treatment. Depending on which group you're assigned to, you'll either receive dexamethasone before each infusion, or you'll skip the preventive medication if your previous infusion went smoothly without an allergic reaction. Researchers will track your infusions, monitor for any allergic reactions, and collect information about your disease activity and any side effects over the course of your treatment.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China